Guggenheim

Analysts are sizing up the second quarter financial results reported by Meta Platforms (NASDAQ: META) after market close Wednesday, including the impact of artificial intelligence initiatives and the recent launch of Threads. The Meta Platforms Analysts: Morgan Stanley analyst Brian Nowak has an...

Streaming giant Netflix Inc (NASDAQ: NFLX) is set to report second-quarter financial results after market close Wednesday, July 19. Here’s a look at what analysts expect from the company that was just nominated for 103 Emmy Awards. Earnings Estimates: For the second quarter, Netflix is...

Electric vehicle giant Tesla Inc (NASDAQ: TSLA) beat analyst estimates for both revenue and earnings per share in the fourth quarter. Here's what the Street has to say Thursday about the quarterly print.  The Tesla Analysts: Bernstein analyst Toni Sacconaghi has an Underperform rating...

Nike Inc (NYSE: NKE) shares rallied Wednesday morning after the company reported shrinking margins but said inventory levels have improved slightly on a quarterly basis. Nike reported fiscal second-quarter adjusted EPS of 85 cents on revenue of $13.32 billion. Both numbers missed consensus analyst...

Merck & Co. Inc. (NYSE: MRK) seems well positioned to surpass 2023 consensus estimates, driven by margin potential, according to Guggenheim. The Analyst: Seamus Fernandez upgraded the rating for Merck from Neutral to Buy, while establishing a price target of $104. The Thesis: The company’...

Kohl's Corporation (NYSE: KSS) shares are down 4% on Friday after the company cut its guidance and said inflation is eating into its sales growth. On Thursday, Kohl's reported second-quarter adjusted EPS of $1.11 on $4.09 billion. Both numbers exceeded consensus analyst estimates of $1.30...

Teladoc Health Inc (NYSE: TDOC) is a market leader in digital services, and the breadth of its services is unmatched, according to Guggenheim. The Teladoc Health Analyst: Sandy Draper initiated coverage of Teladoc Health with a Buy rating and $96 price target. The Teladoc Health Takeaways: The...

Pinterest Inc (NYSE: PINS) shares traded lower Tuesday following a downgrade from Guggenheim. Analyst Michael Morris downgraded the stock from a Buy to a Neutral rating and lowered the price target from $46 to $39. This pushed Pinterest further below a technical channel it traded in. Pinterest...

Scott Minerd, the chief investment officer at Guggenheim Partners, revealed that he regrets missing out on the Shiba Inu (CRYPTO: SHIB) rally. What Happened: In a recent interview with CNBC at the Milken Institute Global Conference, Minerd said he wished he had invested $100,000 in the meme-...

The large online sports betting and iGaming markets has an analyst impressed with the opportunity for DraftKings to keep its competitive advantage and grow with the market. The DraftKings Analyst: Guggenheim analyst Curry Baker initiated Draftkings Inc (NASDAQ: DKNG) with a Buy rating and a $75...

Passage Bio Inc (NASDAQ: PASG) is leveraging the UPenn Gene Therapy Program to access compelling translational research and develop a range of differentiated adeno-associated virus gene therapies for rare central nervous system disorders, according to Guggenheim. The Passage Bio Analyst:...

Bitcoin gained another 13.1% in the past 24 hours and was trading above $23,500 for the first time in history on Thursday morning. The bitcoin rally has triggered a wave of new bullish bitcoin targets on Wall Street, and deVere Group is now calling for at least 50% more upside in 2021. deVere Group...